• AbbVie Leads Injectables Boom Towards $19 Billion by 2029

  • Jan 8 2025
  • Length: 2 mins
  • Podcast

AbbVie Leads Injectables Boom Towards $19 Billion by 2029

  • Summary

  • This episode explores the rapidly expanding world of facial injectables, projected to reach nearly $19 billion by 2029. Driven by a trend towards non-invasive beauty solutions and an aging population, the sector has seen significant contributions from key players like AbbVie and Evolus. The podcast discusses market dynamics, such as the prominence of dermal fillers and Botulinum toxin, while also addressing the challenges of adverse effects and regulations faced by the industry. Additionally, it highlights future advancements, including AI and digital tools, that promise to transform aesthetic treatments.


    Stay connected with Dr. Teri Fisher and keep up with the latest in aesthetic medicine:

    • Visit Dr. Fisher's website for more "sculpted confidence": DrTeriFisher.com
    • Follow Dr. Fisher on Instagram for more inspiration: @DrTeriFisher
    • Listen to Dr. Fisher's long-form podcast: Anti-Aging Insights
    • Book an appointment with Dr. Fisher: antiagingvancouver.com

    👉 Don't forget to subscribe to "Aesthetic Medicine Minute" for your daily quick sip of aesthetic medicine science, and share with friends who might enjoy it too!

    #AestheticMedicineMinute #DrTeriFisher

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about AbbVie Leads Injectables Boom Towards $19 Billion by 2029

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.